- Due to the impact of a cyclosporiasis outbreak, Taco Bell's sales decline exceeded expectations.
- BUZZ - Bloom Energy shares rise due to partnership with California Resources Corporation
- BUZZ - Henry Schein shares fall; the company's third-quarter sales slightly missed expectations
- Pfizer (PFE.US) Q3 profit exceeds expectations, non-COVID products grow by 7%, full-year performance guidance raised
- Iraq and Chevron reach agreement on the West Qurna-2 oil field
- Iraq and Chevron reach agreement on West Qurna-2 oil field
- Pfizer’s revenue declined in the third quarter, dragged down by covid products.
- Pfizer expects full-year revenue between $62 billion and $64 billion and raises its guidance
- Invivyd Grants Options for 175,000 Shares to Seven New Employees
- Keurig Dr Pepper Q3 diluted EPS rises 20% year over year to $0.59; Q3 net sales jump 71% to $7.34 billion year over year
- Labrador Gold Names Raymond Harari President
- Tango Therapeutics CEO Participates in Fireside Chat at Guggenheim Healthcare Innovation Conference
- Precision BioSciences Q3 net loss narrows 65% to $7.59 million
- DATA Communications Management publishes update to financial calendar
- Talen Energy Backs 2026 Adj EBITDA Guidance of $2.05B - $2.20B >TLN
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- BlackRock’s Ethereum ETF sees 580,145 ETH outflow, ETH holds above $2,209
- Regal Rexnord Swings to Q3 Net Loss of $12.3 Million
- Federal Reserve: One more 2026 hike then murkier path – BNY
- Xometry Sees 2026 Adjusted Ebitda $68M-$68.5M >XMTR
- MTY Food, Lefebvre Mutually Agreed That Lefebvre Will Depart Co and Step Dn From Bd, Effective Immediately >MTY.T
- Xometry Raises 2026 Revenue Growth View to at Least 37% From 33%-34% >XMTR
- Madrigal Pharmaceuticals 3Q Rev $431.3M >MDGL
- Axogen Plans Participation in Three Investor Conferences
- PALANTIR TECHNOLOGIES INC. : NORTHLAND CAPITAL RAISES TARGET PRICE TO $210 FROM $200
- Hamilton Lane Declares Quarterly Dividend of $0.60 Per Share
- Barksdale Resources Starts 8,000-Meter Drilling Phase at Sunnyside Copper Project
- Coyote Copper Secures Option to Acquire Gibson Mine for USD 1.4 Million
- INSPIRE MEDICAL SYSTEMS, INC. <INSP.N>: LEERINK PARTNERS RAISES TARGET PRICE TO $68 FROM $67
- Xometry Sees 4Q Adjusted Ebitda $22M-$22.5M >XMTR
- AXSOME THERAPEUTICS, INC. : DEUTSCHE BANK CUTS TARGET PRICE TO $245 FROM $267
- Arvinas 3Q Research and Development Expenses $46.9M >ARVN
- MTY Food: Mandel to Step Dn as Chair and Member of Audit, Compensation, and Governance and Nominating Committees, Effective Immediately >MTY.T
- Talen Energy 3Q EPS $2.88 >TLN
- Olive Resource Capital Cancels All Treasury Shares
- FirstService Residential Wins Property Management Contract for Highlands Community in Pennsylvania
- Cardiff Oncology Participates in UBS Global Biopharma Conference
- Arvinas Q3 net loss widens 54% to $53.9 million; Q3 revenue drops 99% to $500,000
- Henry Schein Raises 2026 Non-GAAP Diluted EPS Forecast to $5.50-$5.56
- Vital Farms swings to $6.46 million net loss in Q3 2026 from year-earlier profit
- Versant Media Q3 net income attributable to company drops 41% to $47 million
- ATHA ENERGY CORP <SASK.V>: VENTUM FINANCIAL INITIATES COVERAGE WITH BUY RATING; TARGET PRICE C$2
- InflaRx Plans Two Phase 2 Izicopan Trials in ANCA-Associated Vasculitis in 2027
- Upstart Q3 2026 Net Income Rises 15% YoY to $36.58 Million; Q3 2026 Revenue Climbs 34% YoY to $370.52 Million
- STAK Names Xiaofei Han Chief Financial Officer
- HEALWELL AI : STIFEL CUTS TARGET PRICE TO C$2 FROM C$2.25
- Rhythm Pharmaceuticals Q3 net loss narrows 22% year over year to $41.37 million
- Foghorn Therapeutics Plans Participation in Three Investor Conferences
- Rapport Therapeutics Participates in Stifel, Jefferies Healthcare Conferences
- BRIEF-Xometry Q3 Adjusted EPS USD 0.28 Vs. IBES Estimate USD 0.18
- C4 Therapeutics to Participate in Guggenheim and Jefferies Healthcare Conferences
- Pasithea Wins FDA Clearance for Phase 2 Trial of PAS-004 in Cutaneous Neurofibromas
- Seres Therapeutics' SER-155 cuts bloodstream infection risk 77% in Phase 1b trial
- PJT Partners presents $1.83 billion in trailing 12-month revenue in investor presentation
- Definium Therapeutics to Participate in Four Healthcare Investor Conferences
- UL Solutions Q3 net income rises 10% to $117 million; Q3 revenue climbs 5% to $823 million
- Tecnisa Implements 1-for-10 Reverse Stock Split
- Madrigal Pharmaceuticals Appoints John C. Reed to Board of Directors
- Axsome Therapeutics to Participate in Four Investor Conferences
- OceanPact agrees to sell two offshore support vessels for USD 86 million
- Vincit names Mikko Salokangas interim Digital Solutions business director
- North Sky Metals completes maiden drill program at Natlan project in British Columbia
- Main Street Capital Raises Monthly Dividend to $0.27 Per Share
- DigitalOcean Q3 2026 Swings to Net Loss of $42.61 Million; Q3 Revenue Rises 40% to $321.19 Million
- ESTEE LAUDER <EL.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $124 FROM $117
- MARRIOTT INTERNATIONAL INC. <MAR.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $420 FROM $392
- Ashley Gold completes LiDAR, drone magnetic surveys at Tak project
- Opus Genetics Participates in Fireside Chat at Guggenheim Healthcare Innovation Conference
- LGI Homes Q3 2026 net income rises 25% year over year to $24.56 million
- VERTEX PHARMACEUTICALS INCORPORATED <VRTX.O>: BMO RAISES TARGET PRICE TO $620 FROM $600
- Knife River Q3 net income falls to $137.9 million; Q3 revenue rises 6% to $1.28 billion
- Aptiv Sees 4Q Sales $3.11B-$3.21B >APTV
- ARTHUR J. GALLAGHER & CO. : BMO CUTS TO MARKET PERFORM FROM OUTPERFORM; RAISES TARGET PRICE TO $295 FROM $255
- Angel Oak Mortgage REIT Swings to Q3 2026 Net Loss of $16.67 Million From Year-Earlier Profit
- AdaptHealth swings to Q3 net loss of $168.2 million; Q3 net revenue rises 11% to $745.6 million
- Fortune Bay reports anomalous radioactivity in six drill holes at Murmac, Strike uranium projects
- Bowhead Specialty Q3 2026 net income falls 15% to $12.94 million
- Parabilis Medicines Participates in Three Investor Conferences
- Glaukos Plans Participation in Four Healthcare Investor Conferences
- Aptiv Sees 4Q Adj EPS $1.35-Adj EPS $1.55 >APTV
- Versant Media Group 3Q EPS 34c >VSNT
- Aptiv Sees 4Q Cont Ops EPS 95c-EPS $1.15 >APTV
- BRIEF-Precision BioSciences, Inc. Q3 Income From Operations USD -20.428 Million
- Aeva Partners With Micro-Epsilon on Factory Automation Sensors
- Broadridge Financial 1Q Adj EPS $1.56 >BR
- -- Earnings Flash (RRX) Regal Rexnord Corporation Posts Q3 Adjusted EPS $2.90 per Share, vs. FactSet Est of $2.65
- -- Earnings Flash (RRX) Regal Rexnord Corporation Reports Q3 Revenue $1.59B, vs. FactSet Est of $1.56B
- -- Earnings Flash (RYTM) Rhythm Pharmaceuticals Posts Q3 Net Loss $0.61 a Share, vs. FactSet Est of $0.69 Loss
- Rockpoint Gas Storage Q2 Net Earnings Rises
- -- Earnings Flash (BR) Broadridge Financial Solutions, Inc. Reports Q1 Revenue $1.67B, vs. FactSet Est of $1.65B
- -- Earnings Flash (LGIH) LGI Homes Posts Q3 Adjusted EPS $1.05, vs. FactSet Est of $0.73
- -- Earnings Flash (XMTR) Xometry, Inc. Posts Q3 Adjusted EPS $0.28 per Share
- -- GUIDANCE: (XMTR) Xometry, Inc. Expects Q4 Revenue Range $254.0M - $256.0M
- -- Earnings Flash (XMTR) Xometry, Inc. Reports Q3 Revenue $252.4M, vs. FactSet Est of $235.5M
- --Earnings Flash (MDGL) Madrigal Pharmaceuticals Posts Q3 EPS $1.83
- -- Earnings Flash (TEVA) Teva Pharmaceutical Industries Ltd. Posts Q3 Adjusted EPS $0.86 per Share, vs. FactSet Est of $0.72
- -- Earnings Flash (MDGL) Madrigal Pharmaceuticals, Inc. Reports Q3 Revenue $431.3M, vs. FactSet Est of $404.2M
